Drug Overviews page

In this section Hide

The Drug Overviews page lists drugs that your organization is monitoring using signal management. Your organization can monitor a drug if the data mining runs behind the signal configuration produce results for the drug.

General activities

The following links appear at the top of the page for users with the Manage Signaling Terms permission:

  1. Add Drug
  2. Manage Signaling Terms—for interactive signal configurations only
  3. Auto-Assign to Reviewers
  4. Modify Automatic Assignments

The following links appear above the table for all users:

  1. Columns

Note: The Columns link is replaced by the Columns and Rows link if you enable the Allow SQL Where Clause on Signals Tab user preference.

  1. Print
  2. Download

Row-specific activities

The following links appear in the row (Row menu) menu for each drug:

The following options appear in the row menu (Row menu) for users with the Manage Signaling Terms permission:

Field descriptions—Drug Overviews page

Column

Description

Drug

Name of the drug.

If you set the following user preferences and configure the Drugs tab, drug names might appear as links:

  • Drug Profile Configuration

  • Drug Profile Layout

When you click a drug name, the Drug Profile page appears. The drug is listed as the Primary Drug for the drug profile. If the drug profile layout is for multiple drugs, you can specify comparator drugs. For more information, see About drug profiles and layouts.

Group

Name of the group associated with the drug.

<event count type>

Number of cases that include the drug and have a certain characteristic. For example, the Fatal column shows the number of reports since the previous review period that include the drug and a fatal outcome.

You can click the count in each <event count type> column to display the Drug-Event Combinations page for the drug.

If an administrator specified a review period for the signal configuration, the count in each column on the Drug-Event Combinations page is for the drug's most recent review period. As a result, the counts for each drug in the Drug-Event Combinations page might reflect different review periods.

Allow Auto

Whether the Participates in automatic assignment option is selected in the Add/Edit Drug dialog box for the drug.

Entry Date

Date on which the most recent note was entered for the drug.

Review Period

Frequency of evaluations for this drug, for example, 3 months, 6 months, or 1 year.

Typically, the Default view associated with the drug in the Add/Edit Drug dialog box has the same review period. When the drug and the Default view have the same review period, the scores, counts, and other data for the drug in the Drug-Event Combinations page reflect information since the last review period.

Note: This column appears only if an administrator specified a review period for the signal configuration.

View Name

Name of the Default view selected in the Add/Edit Drug dialog box for the drug. Empirica Signal applies the view when you select the drug in the Drug-Event Combinations page.

If this column is empty, Empirica Signal applies the Default signal view for the signal management configuration.